Coenzyme Q10 supplementation in burn patients: a double-blind placebo-controlled randomized clinical trial.

"Declarations Ethics approval and consent to participateThis study was approved by the Ethics Committee of Isfahan University of Medical Sciences (code; IR.MUI.RESEARCH.REC.1400.109). This research also reached the registration of clinical trials in Iran affiliated with WHO (registration ID: IRCT20201129049534N3), available at https://en.irct.ir/trial/56570. Also, before the trial, all patients were requested to complete a written informed consent form. Consent for publicationAll authors approved the final version of the manuscript and agreed for all aspects of the work to be published. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding Isfahan University of Medical Sciences fully supported our study with grant number 3400150, Isfahan, Iran."

"This study was a parallel randomized, double-blind, placebo-controlled trial assessing the effect of CoQ10 supplementation in burn patients admitted to the ICU compared to the placebo. The study was conducted in Imam Musa Kazem Hospital, the burn center in Isfahan, Iran, from June 2021 to March 2022. The study protocol was approved by the ethics committee of the Isfahan University of Medical Sciences (IR.MUI.RESEARCH.REC.1400.109). Our clinical trial was registered at IRCT.ir (IRCT20201129049534N3). Patients or next of kin provided written informed consent for participating in this study. Declarations: Ethics approval and consent to participateThis study was approved by the Ethics Committee of Isfahan University of Medical Sciences (code; IR.MUI.RESEARCH.REC.1400.109). This research also reached the registration of clinical trials in Iran affiliated with WHO (registration ID: IRCT20201129049534N3), available at https://en.irct.ir/trial/56570. Also, before the trial, all patients were requested to complete a written informed consent form.: Consent for publicationAll authors approved the final version of the manuscript and agreed for all aspects of the work to be published.: Competing interestsThe authors declare no competing interests. Ethics approval and consent to participate: This study was approved by the Ethics Committee of Isfahan University of Medical Sciences (code; IR.MUI.RESEARCH.REC.1400.109). This research also reached the registration of clinical trials in Iran affiliated with WHO (registration ID: IRCT20201129049534N3), available at https://en.irct.ir/trial/56570. Also, before the trial, all patients were requested to complete a written informed consent form."